Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin

Autor: Bethany L. Walton, Kimberley Foley, Maria M. Aleman, Edward M. Conway, Jonathan H. Foley, Alisa S. Wolberg, Micaela Harrasser, Victor Lei, Alice M. O'Byrne
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Plasmin
medicine.medical_treatment
PPACK
Phe-Pro-Arg-chloromethylketone

Complement Pathway
Alternative

lcsh:Medicine
Complement C3-C5 Convertases
030204 cardiovascular system & hematology
tPA
tissue-type plasminogen activator

0302 clinical medicine
Leukocytes
Fibrinolysin
Complement Activation
Complement component 5
IL-8
interleukin-8

TAT
thrombin antithrombin

lcsh:R5-920
Fibrinolysis
Thrombin
Complement C5
Complement C4
hemic and immune systems
General Medicine
Complement C3
Complement C2
Complement C9
3. Good health
Complement C6
Venous thrombosis
Coagulation
Complement C3b
MAC
membrane attack complex

lcsh:Medicine (General)
FDP
fibrin degradation product

medicine.drug
Research Paper
circulatory and respiratory physiology
VWF
von Willebrand factor

NETs
neutrophil extracellular traps

Complement Activating Enzymes
Complement
chemical and pharmacologic phenomena
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
IVC
inferior vena cava

medicine
R751
arginine 751

Humans
Thrombus
MCP1-1
monocyte chemoattracant protein-1

business.industry
lcsh:R
FeCl3
ferric chloride

Thrombosis
medicine.disease
Complement system
030104 developmental biology
VFKck
Val-Phe-Lys-chloromethylketone

Immunology
business
Complement membrane attack complex
PAR1
protease activated receptor 1
Zdroj: EBioMedicine, Vol 5, Iss C, Pp 175-182 (2016)
EBioMedicine
ISSN: 2352-3964
Popis: Thrombus formation leading to vaso-occlusive events is a major cause of death, and involves complex interactions between coagulation, fibrinolytic and innate immune systems. Leukocyte recruitment is a key step, mediated partly by chemotactic complement activation factors C3a and C5a. However, mechanisms mediating C3a/C5a generation during thrombosis have not been studied. In a murine venous thrombosis model, levels of thrombin–antithrombin complexes poorly correlated with C3a and C5a, excluding a central role for thrombin in C3a/C5a production. However, clot weight strongly correlated with C5a, suggesting processes triggered during thrombosis promote C5a generation. Since thrombosis elicits fibrinolysis, we hypothesized that plasmin activates C5 during thrombosis. In vitro, the catalytic efficiency of plasmin-mediated C5a generation greatly exceeded that of thrombin or factor Xa, but was similar to the recognized complement C5 convertases. Plasmin-activated C5 yielded a functional membrane attack complex (MAC). In an arterial thrombosis model, plasminogen activator administration increased C5a levels. Overall, these findings suggest plasmin bridges thrombosis and the immune response by liberating C5a and inducing MAC assembly. These new insights may lead to the development of strategies to limit thrombus formation and/or enhance resolution.
Highlights • Thrombin is not a major direct contributor to C5a generation during venous thrombosis in mice. • Plasmin, a protease generated in response to thrombin generation and fibrin deposition, efficiently cleaves C5 to C5a. • In an arterial thrombosis model, administration of a plasminogen activator augments C5a plasma levels. • Plasmin participates in immunothrombosis, liberating chemotactic C5a and inducing assembly of the procoagulant C5b-9. Venous and arterial thrombosis are major causes of death and morbidity. Leukocytes are early and active participants in thrombus formation, recruited partly by complement factor C5a. We examined how C5a is generated in the setting of thrombosis. In venous thrombosis in mice, we show that thrombin, a key clot-promoting enzyme, is not a major contributor to C5a generation. Rather, plasmin, a fibrinolytic enzyme formed in response to thrombin generation and clot formation, efficiently generates C5a. The findings were validated in an arterial thrombosis model in mice. These insights may be valuable in developing therapeutic strategies to limit thrombus formation.
Databáze: OpenAIRE